BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 828967)

  • 1. The occurrence of free vs. conjugated MHPG in non-human and human primate brain.
    Maas JW; Landis H; Dekirmenjian H
    Psychopharmacol Commun; 1976; 2(5-6):403-10. PubMed ID: 828967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma.
    Karoum F; Moyer-Schwing J; Potkin SG; Wyatt RJ
    Brain Res; 1977 Apr; 125(2):333-9. PubMed ID: 856412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.
    Elsworth JD; Redmond DE; Roth RH
    Brain Res; 1982 Mar; 235(1):115-24. PubMed ID: 7188317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain.
    Roffman M; Kling MA; Cassens G; Orsulak PJ; Reigle TG; Schildkraut JJ
    Commun Psychopharmacol; 1977; 1(3):195-206. PubMed ID: 606473
    [No Abstract]   [Full Text] [Related]  

  • 5. Vanilmandelic acid (VMA), free and conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human ventricular fluid.
    Karoum F; Gillin JC; McCullough D; Wyatt RJ
    Clin Chim Acta; 1975 Aug; 62(3):451-5. PubMed ID: 1164814
    [No Abstract]   [Full Text] [Related]  

  • 6. Is 3,4-dihydroxyphenylglycol the major route of central norepinephrine metabolism in rat brain?
    Karege F; Gaillard JM
    Neurosci Lett; 1986 Aug; 69(1):78-83. PubMed ID: 3748468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals.
    Maas JW; Hattox SE; Landis DH; Roth RH
    Eur J Pharmacol; 1977 Dec; 46(3):221-8. PubMed ID: 412681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of chronic imipramine treatment on brain and urine MHPG levels in the rat.
    Sedlock ML; Edwards DJ
    Biol Psychiatry; 1985 Aug; 20(8):858-65. PubMed ID: 4027302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.
    Riederer P; Birkmayer W; Seemann D; Wuketich S
    J Neural Transm; 1977; 41(4):241-51. PubMed ID: 925685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional characteristics of noradrenaline turnover as reflected in the brain levels of MHPG-SO4].
    Kohno Y
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):175-92. PubMed ID: 6345303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography.
    Warsh JJ; Godse DD; Cheung SW; Li PP
    J Neurochem; 1981 Mar; 36(3):893-901. PubMed ID: 7205279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs.
    Artigas F; Sarrias MJ; Adell A; Gelpí E
    Life Sci; 1986 Oct; 39(17):1571-8. PubMed ID: 3762318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental difference in noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) levels in rat whole brain.
    Kohno Y; Tanaka M; Nakagawa R; Ida Y; Iimori K; Nagasaki N
    Kurume Med J; 1981; 28(1):95-8. PubMed ID: 7321520
    [No Abstract]   [Full Text] [Related]  

  • 14. The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
    Maas JW; Hattox SE; Landis DH; Roth RH
    Brain Res; 1976 Dec; 118(1):167-73. PubMed ID: 825199
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct assay of 3-methoxy-4-hydroxy-phenylglycol (MHPG) in human saliva; a new approach in the assessment of noradrenergic function.
    Stefănescu AM; Popa M; Dumitriu L
    Endocrinologie; 1989; 27(2):93-6. PubMed ID: 2799243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites.
    Maas JW
    Adv Biochem Psychopharmacol; 1984; 39():45-55. PubMed ID: 6431762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain.
    Roffman M; Reigle T; Orsulak P; Schildkraut JJ
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):403-17. PubMed ID: 1135507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine withdrawal: effects on brain levels of MHPG-SO4 in the rat.
    Cassens G; Kuruc A; Orsulak PJ; Schildkraut JJ
    Commun Psychopharmacol; 1979; 3(4):217-23. PubMed ID: 575083
    [No Abstract]   [Full Text] [Related]  

  • 19. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
    Roth RH; Elsworth JD; Redmond DE
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem stability of brain 3-methoxy-4-hydroxyphenylethyleneglycol and 3,4-dihydroxyphenylethyleneglycol in the rat and mouse.
    Warsh JJ; Godse DD; Li PP; Cheung SW
    J Neurochem; 1981 Mar; 36(3):902-7. PubMed ID: 7205280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.